KalmCold Reduces URTI Symptoms

March 1, 2010

2 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

LUCKNOW, IndiaAccording a recently published Indian study, KalmCold (from Natural Remedies), an extract of Andrographis paniculata, was effective in reducing symptoms of upper respiratory tract infection (URTI) (Phytomed. 2010; 17(3-4):178-185). The double blind, placebo-controlled clinical study randomized 223 patients of both sexes into two groups to receive either 200 mg/d of KalmCold or placebo.

In both the treatments, mean scores of all symptoms showed a decreasing trend from day 1 to day 3, but from day 3 to day 5 most of the symptoms in placebo-treated group either remained unchanged (cough, headache and earache) or got aggravated (sore throat and sleep disturbance), whereas in KalmCold treated group all symptoms showed a decreasing trend. Within groups, mean scores of symptoms in both the groups decreased significantly (P0.05) from day 1 to day 3 and day 5, while from day 3 to day 5 all symptoms except expectoration in placebo group did not improve significantly, whereas in KalmCold treated group all symptoms improved significantly (P0.05) except earache. Comparing mean between both groups, all symptoms at day 1 and day 3 were found to be the same, while at day 5 all symptoms except earache in KalmCold treated group improved significantly (P0.05) than placebo group. Similarly, within groups, overall scores of all symptoms in both the groups decreased significantly (P0.05) from day 1 to day 3 and day 5, while from day 3 to day 5 placebo group did not improve significantly, whereas KalmCold treated group showed significant improvement (P0.05). On between groups analysis, KalmCold group showed significant reduction (P0.05) in overall symptom scores as compared to placebo group. In both placebo- and KalmCold-treated groups, there were only a few minor adverse effects with no significant difference in occurrence (Z = 0.63; P>0.05). The comparison of overall efficacy of KalmCold over placebo was found to be significant (P 0.05) and it was 2.1 times (52.7 percent) higher than placebo.

 

 

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like